GDP Non-Compliance Report for Czech Company D-Pharm
Recommendation
Monday, 3 November 2025 14.00 - 16.00 h
A reliable Basis for Qualifying Service Providers?
Register now for ECA's GMP Newsletter
On 21st July 2015 the competent authority of the Czech Republic has issued a EU GDP Non-Compliance report to a wholesale distributor. According to that report the company D-Pharm located at Makovského námestí 2, Brno, 616 00 does not comply with the Good Distribution Practice requirements.
As the report filed in EudraGMDP (the EU wide GMP and GDP compliance database) mentions, the company D-Pharm seriously violated the conditions on which its permission for activities is based, and they fell short of the obligations set out in § 77 of the Act on Pharmaceuticals. Further details on the concrete GDP findings have not been published.
Source EudraGMDP Database
Related GMP News
14.10.2025MHRA Blog Post: GDP in the Aviation and Marine Sectors
14.10.2025Commercial GDP Certificates: Helpful Tool or Questionable Assurance?
14.10.2025Mean Kinetic Temperature (MKT): Calculation, Benefits, and Limitations
14.10.2025Fiscal Importation within the EEA - Discussion of ECA GDP Survey Results
16.09.2025BioPhorum Survey on -40 °C Drug Substance Storage Practices